WCN24-2592 GENETIC DIAGNOSIS OF CHRONIC KIDNEY DISEASE: A SINGLE-CENTER STUDY

WCN24-2592 GENETIC DIAGNOSIS OF CHRONIC KIDNEY DISEASE: A SINGLE-CENTER STUDY

Saved in:

Bibliographic Details
Main Authors:	EUGENIA FLORES, Mariana Ursino, Mariano Forrester, Romina Iriarte, Fernando Lombi, Matias Monkowski, Jose Diaz, Liliana Borda, Hernán Trimarchi
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924008209
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1780 A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE
by: Mariana Ursino, et al.
Published: (2024-04-01)

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01)

WCN24-2582 EPIDEMIOLOGICAL PROFILE OF KDIGO STAGE III ACUTE KIDNEY INJURY WITH THE NEED FOR RENAL SUPPORT THERAPY IN THE INTENSIVE CARE UNIT: OUR EXPERIENCE
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-2542 HEMODYNAMIC INESTABILITY IN DIALYSIS AS A PREDICTOR OF MORTALITY IN CRITICALLY ILL PATIENTS
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-1884 THROMBOTIC MICROANGIOPATHY, SYSTEMIC LUPUS ERYTHEMATOSUS, AND A VITAMIN B12 MUTATION: A CAUSE OF PRIMARY ATYPICAL HEMOLYTIC UREMIC SYNDROME?
by: Jose Heriberto Díaz Góngora, et al.
Published: (2024-04-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?
by: Hernán Trimarchi, et al.
Published: (2012-01-01)

WCN25-2592 Comparison of the Clinical Profile of IgA Nephropathy with Other Primary Glomerulonephritis in Nepalese Patients Undergoing Native Kidney Biopsy
by: Kamal Saud, et al.
Published: (2025-02-01)

Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis
by: H. Trimarchi, et al.
Published: (2018-01-01)

WCN24-2184 SURVIVING ACUTE KIDNEY INJURY, THE NEPHROLOGIST'S INTERVENTION AGAINST THE SILENT ENEMY
by: Maria Marina Papaginovic Leiva, et al.
Published: (2024-04-01)

WCN24-2607 THROMBOTIC MICROANGIOPATHY AND KIDNEY TRANSPLANTATION (KT). A SINGLE CENTER EXPERIENCE
by: Alejandra Ines Espinoza, et al.
Published: (2024-04-01)

WCN24-1808 TREATMENT OF SECONDARY HYPERPARATHYROIDISM WITH ETELCALCETIDE IN ARGENTINA
by: Daniela Wojtowicz, et al.
Published: (2024-04-01)

WCN24-2585 Outcomes of commercial kidney transplantation: single center experience
by: Ali M. Shendi, et al.
Published: (2024-04-01)

WCN24-20 KIDNEY RE-TRANSPLANTATION IN CHILDREN
by: Mohamad Bassam Said
Published: (2024-04-01)

WCN24-2197 INTRADERMAL HEPATITIS B VACCINATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN DIALYSIS
by: Daniela Wojtowicz, et al.
Published: (2024-04-01)

WCN24-2521 FEASIBILITY AND SAFETY OF PERCUTANEOUS KIDNEY BIOPSY IN SMALL KIDNEYS: BREAKING THE PARADIGM
by: Alejandro Garcia-Rivera, et al.
Published: (2024-04-01)

WCN24-1669 DETERMINING THE PRESENCE OF TORQUE-TENO VIRUS IN KIDNEY TRANSPLANT PATIENTS
by: Ruben Schiavelli, et al.
Published: (2024-04-01)

WCN24-1282 BARRIERS AND FACILITATORS TO ADHERENCE TO A HEALTHY DIET IN CHRONIC KIDNEY DISEASE
by: Xochitl Berenice Trigueros Flores, et al.
Published: (2024-04-01)

WCN24-1624 CAUSES OF EXCLUSION OF LIVING KIDNEY DONORS IN THREE TRANSPLANT CENTERS
by: Maria Nieves Aran, et al.
Published: (2024-04-01)

WCN24-2498 RARE KIDNEY COMPLICATIONS WITH IFOSFAMIDE: INSIPIDUS DIABETES AND KIDNEY TUBULAR ACIDOSIS
by: Lorena Fernandes Maia, et al.
Published: (2024-04-01)

WCN24-2535 Epidemiology of ADPKD in a medical center in Argentina
by: Hernan Dario Huertas Estrada, et al.
Published: (2024-04-01)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
by: H. Trimarchi, et al.
Published: (2014-01-01)

WCN24-1652 BENEFIT AND SAFETY OF KIDNEY BIOPSY IN THE ELDERLY. BREAKING THE PARADIGM
by: Omar Sanchez-Vazquez, et al.
Published: (2024-04-01)

WCN24-2349 MUSCLE QUALITY IN CHRONIC KIDNEY DISEASE
by: F.E.R.N.A.N.D.O. MARGULIS, et al.
Published: (2024-04-01)

WCN24-1402 ANCA-ASSOCIATED GLOMERULONEPHRITIS IN DIABETIC KIDNEY DISEASE: CASE REPORT
by: Germán Landeros, et al.
Published: (2024-04-01)

WCN24-2503 ARE THE ACUTE KIDNEY INJURY CONCEPTS RIGHT BETWEEN THE MEDICAL POPULATION?
by: Lilia Maria Rizo Topete, et al.
Published: (2024-04-01)

WCN24-590 ACUTE KIDNEY INJURY AFTER LIVER TRANSPLANT, A CENTER REPORT
by: Saghar Chehrazi, et al.
Published: (2024-04-01)

WCN24-847 SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN24-1470 EVOLUTION OF KIDNEY FUNCTION AT 24 MONTHS IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTORY OF COVID-19
by: Ruben Schiavelli, et al.
Published: (2024-04-01)

WCN24-1290 COMPARISON OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: Saul Neftali Rolon Barbosa, et al.
Published: (2024-04-01)

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY
by: Hernán Trimarchi, et al.
Published: (2024-04-01)

WCN24-1293 ASSOCIATION OF CHRONOTYPE WITH NUTRITIONAL STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: PILARCAROLINA CASTRO-MATA, et al.
Published: (2024-04-01)

WCN24-1069 VALIDATION OF THE KIDNEY FAILURE RISK EQUATION (KFRE) AND ITS APPLICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE FOLLOWED BY THE RENAL HEALTH-CARE PROGRAM OF URUGUAY
by: Dugan González, et al.
Published: (2024-04-01)

WCN24-1899 RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION
by: Adriana M. Lituma, et al.
Published: (2024-04-01)

WCN24-2518 VITAMIN B COMPLEX IN KIDNEY TRANSPLANT RECIPIENTS
by: I.S.R.A.E.L. RIVAS, et al.
Published: (2024-04-01)

WCN24-2644 VITAMIN B COMPLEX IN LIVING KIDNEY DONORS
by: I.S.R.A.E.L. RIVAS, et al.
Published: (2024-04-01)

WCN24-421 Mineral and bone disorders in chronic kidney disease
by: Senoussi Abdelkerim CHARFADINE, et al.
Published: (2024-04-01)

WCN24-1516 THERAPEUTIC APHERESIS IN KIDNEY TRANSPLANTATION; EMERGING TRENDS
by: Chimezie Okwuonu, et al.
Published: (2024-04-01)

WCN24-1557 NEUTROPHIL-LYMPHOCYTE AND PLATELETLYMPHOCYTE RATIO WITHIN HEMODIALYSIS AND KIDNEY TRANSPLANT PATIENTS
by: Milagros Melissa Flores Fonseca, et al.
Published: (2024-04-01)

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)